Home
Mail
News
Sport
Finance
Celebrity
Style
Weather
Mobile
Messenger
Movies
More
Yahoo
Mail
News
Market Data
Crypto
Bank of England
Money Matters
Property
Top Stocks
Work & Management
Industry News
Brexit
My Portfolio
My Screeners
Watchlists
Videos
UK markets close in 3 hours 31 minutes
FTSE 100
8,334.41
+20.74
(+0.25%)
FTSE 250
20,414.84
+1.76
(+0.01%)
AIM
777.81
+1.39
(+0.18%)
GBP/EUR
1.1616
-0.0008
(-0.07%)
GBP/USD
1.2484
-0.0026
(-0.21%)
Bitcoin GBP
49,879.01
-994.59
(-1.96%)
Money
How to make a tax-free income
Tips for making money that won't be taxed
Lexicon Pharmaceuticals, Inc. (LXRX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.7700
-0.0600
(-3.28%)
At close: 04:00PM EDT
1.7518
-0.02
(-1.03%)
After hours:
07:44PM EDT
Summary
Chart
Conversations
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
2,310
1,204
139
298
23,995
Cost of revenue
116
85
0
0
1,929
Gross profit
2,194
1,119
139
298
22,066
Operating expenses
Research development
61,233
58,887
52,816
55,046
153,621
Selling general and administrative
126,902
113,982
48,083
32,342
47,230
Total operating expenses
188,135
172,869
100,899
87,388
200,851
Operating income or loss
-185,941
-171,750
-100,760
-87,090
-178,785
Interest expense
16,228
13,101
2,780
802
14,544
Total other income/expenses net
-
-
-
-
131,988
Income before tax
-193,582
-177,119
-101,944
-87,758
-58,574
Income tax expense
-
-
-
0
0
Income from continuing operations
-193,582
-177,119
-101,944
-87,758
-58,574
Net income
-193,582
-177,119
-101,944
-87,758
-58,574
Net income available to common shareholders
-193,582
-177,119
-101,944
-87,758
-58,574
Basic EPS
-0.62
-0.79
-0.62
-0.60
-0.53
Diluted EPS
-0.62
-0.79
-0.62
-0.60
-0.53
Basic average shares
165,733
221,130
165,733
145,652
110,841
Diluted average shares
165,733
221,130
165,733
145,652
110,841
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.